Simplex Trading’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Simplex Trading’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,500	Closed	-$2K	–	10160
2024 Q1	$2K	Buy	13,500 +12,400	+1,127%	+$30.7K	﹤0.01%	8503
2023 Q4	$2K	Buy	1,100 +200	+22%	+$354	﹤0.01%	8402
2023 Q3	$1K	Sell	900 -100	-10%	-$240	﹤0.01%	8477
2023 Q2	$3K	Buy	+1,000	New	+$3.85K	﹤0.01%	8333
2022 Q4	–	Sell	-2,300	Closed	-$27K	–	10788
2022 Q3	$27K	Buy	2,300 +300	+15%	+$3.93K	﹤0.01%	7212
2022 Q2	$25K	Buy	2,000 +1,400	+233%	+$13K	﹤0.01%	7364
2022 Q1	$6K	Buy	+600	New	+$6.61K	﹤0.01%	9347

Simplex Trading's KNTE Position: Q2 2024 in Review

Simplex Trading sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 21,764 shares — an estimated $57K sold.

Simplex Trading first reported a position in KNTE in Q2 2022 and held it in 7 quarters. The position peaked at $105K in Q4 2023. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Simplex Trading reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Simplex Trading sold 21,764 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $57K.
Simplex Trading first reported a position in Kinnate Biopharma Inc. Common Stock in Q2 2022 and held it in 7 quarters.
Simplex Trading's Kinnate Biopharma Inc. Common Stock position peaked at $105K in Q4 2023.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.